|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Artificial Intelligence in Healthcare:Review and Prediction Case Studies显示文摘Artificial intelligence(AI)has been developing rapidly in recent years in terms of software algorithms,hardware implementation,and applications in a vast number of areas.In this review,we summarize the latest developments of applications of AI in biomedicine,including disease diagnostics,living assistance,biomedical information processing,and biomedical research.The aim of this review is to keep track of new scientific accomplishments,to understand the availability of technologies,to appreciate the tremendous potential of AI in biomedicine,and to provide researchers in related fields with inspiration.It can be asserted that,just like AI itself,the application of AI in biomedicine is still in its early stage.New progress and breakthroughs will continue to push the frontier and widen the scope of AI application,and fast developments are envisioned in the near future.Two case studies are provided to illustrate the prediction of epileptic seizure occurrences and the filling of a dysfunctional urinary bladder. | Guoguang Rong Arnaldo Mendez Elie Bou Assi Bo Zhao Mohamad Sawan | 2020 | Engineering2020，6，3： | 7 |
| 2 | Intraoperative laparoscopic complications for urological cancer procedures显示文摘AIM: To structure the rate of intraoperative complications that requires an intraoperative or perioperative resolution. METHODS: We perform a literature review of Medline database. The research was focused on intraoperative laparoscopic procedures inside the field of urological oncology. General rate of perioperative complications in laparoscopic urologic surgery is described to be around 12.4%. Most of the manuscripts published do not make differences between pure intraoperative, intraoperative with postoperative consequences and postoperative complications. RESULTS: We expose a narrative statement of complications, possible solutions and possible preventions for most frequent retroperitoneal and pelvic laparoscopic surgery. We expose the results with the following order: retroperitoneal laparoscopic surgery(radical nephrectomy, partial nephrectomy, nephroureterectomy and adrenalectomy) and pelvic laparoscopic surgery(radical prostatectomy and radical cystectomy).CONCLUSION: Intraoperative complications vary from different series. More scheduled reports should be done in order to better understand the real rates of complications. | Sergio Fernández-Pello Montes Ivan Gonzalez Rodríguez Rodrigo Gil Ugarteburu Luis Rodríguez Villamil Begoa Diaz Mendez Patricio Suarez Gil Javier Mosquera Madera | 2015 | World Journal of Clinical Cases2015，3，5： | 4 |
| 3 | Pulmonary complications of hepatic diseases显示文摘Severe chronic liver disease(CLD) may result from portal hypertension, hepatocellular failure or the combination of both. Some of these patients may develop pulmonary complications independent from any pulmonary pathology that they may have. Among them the hepatopulmonary syndrome(HPS), portopulmonary hypertension(PPH) and hepatic hydrothorax(HH) are described in detail in this literature review. HPS is encountered in approximately 15% to 30% of the patients and its presence is associated with increase in mortality and also requires liver transplantation in many cases. PPH has been reported among 4%-8% of the patient with CLD who have undergone liver transplantation. The HH is another entity, which has the prevalence rate of 5% to 6% and is associated in the absence of cardiopulmonary disease. These clinical syndromes occur in similar pathophysiologic environments. Most treatment modalities work as temporizing measures. The ultimate treatment of choice is liver transplant. This clinical review provides basic concepts; pathophysiology and clinical presentation that will allow the clinician to better understand these potentially life-threatening complications. This article will review up-to-date information on the pathophysiology, clinical features and the treatment of the pulmonary complications among liver disease patients. | Salim R Surani Yamely Mendez Humayun Anjum Joseph Varon | 2016 | World Journal of Gastroenterology2016，22，26： | 3 |
| 4 | Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants显示文摘 | George K. Siberry Paige L. Williams Hermann Mendez George R. Seage Denise L. Jacobson Rohan Hazra Kenneth C. Rich Raymond Griner Katherine Tassiopoulos Deborah Kacanek Lynne M. Mofenson Tracie Miller Linda A. DiMeglio D. Heather Watts | 2012 | AIDS2012，，9： | 2 |
| 5 | Perioperative risk factors associated with delayed graft function following deceased donor kidney transplantation:A retrospective,single center study显示文摘BACKGROUND There is an abundant need to increase the availability of deceased donor kidney transplantation(DDKT)to address the high incidence of kidney failure.Challenges exist in the utilization of higher risk donor organs into what appears to be increasingly complex recipients;thus the identification of modifiable risk factors associated with poor outcomes is paramount.AIM To identify risk factors associated with delayed graft function(DGF).METHODS Consecutive adults undergoing DDKT between January 2016 and July 2017 were identified with a study population of 294 patients.The primary outcome was the occurrence of DGF.RESULTS The incidence of DGF was 27%.Under logistic regression,eight independent risk factors for DGF were identified including recipient body mass index≥30 kg/m^(2),baseline mean arterial pressure<110 mmHg,intraoperative phenylephrine administration,cold storage time≥16 h,donation after cardiac death,donor history of coronary artery disease,donor terminal creatinine≥1.9 mg/dL,and a hypothermic machine perfusion(HMP)pump resistance≥0.23 mmHg/mL/min.CONCLUSION We delineate the association between DGF and recipient characteristics of preinduction mean arterial pressure below 110 mmHg,metabolic syndrome,donorspecific risk factors,HMP pump parameters,and intraoperative use of phenylephrine. | Nicholas V Mendez Yehuda Raveh Joshua J Livingstone Gaetano Ciancio Giselle Guerra George W Burke III Vadim B Shatz Fouad G Souki Linda J Chen Mahmoud Morsi Jose M Figueiro Tony M Ibrahim Werviston L DeFaria Ramona Nicolau-Raducu | 2021 | World Journal of Transplantation2021，11，4： | 2 |
| 6 | Phytoremediation of mine tailings in temperate and arid environments显示文摘 | Monica O. Mendez Raina M. Maier | 2008 | Reviews in Environmental Science and Bio/Technology2008，，1： | 2 |
| 7 | Methodology for inventorying greenhouse gas emissions from global cities显示文摘 | Christopher Kennedy Julia Steinberger Barrie Gasson Yvonne Hansen Timothy Hillman Miroslav Havránek Diane Pataki Aumnad Phdungsilp Anu Ramaswami Gara Villalba Mendez | 2009 | Energy Policy2009，，9： | 2 |
| 8 | Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence显示文摘Cardiovascular diseases(CVDs) remain the leading cause of death in the world and in most developed countries. Patients with type 2 diabetes mellitus(T2DM)suffer from both microvascular and macrovascular diseases and therefore have higher rates of morbidity and mortality compared to those without T2DM. If current trends continue, the Center for Disease Control and Prevention estimates that 1 in 3 Americans will have T2DM by year 2050. As a consequence of the controversy surrounding rosiglitazone and the increasing prevalence of diabetes and CVDs, in 2008 the Food and Drug Administration(FDA) established new expectations for the evaluation of new antidiabetic agents, advising for pre and,in some cases, post-marketing data on major cardiovascular events. As a direct consequence, there has been a paradigm shift in new antidiabetic agents that has given birth to the recently published American Diabetes Association/European Association for the Study of Diabetes consensus statement recommending sodium-glucose cotransporter-2 inhibitors(SGLT2i) and glucagon like peptide-1 receptor agonists(GLP-1RA) in patients with T2DM and established CVD. As a result of over a decade of randomized placebo controlled cardiovascular outcome trials, the aforementioned drugs have received FDA approval for risk reduction of cardiovascular(CV) events in patients with T2DM and established CV disease.SGLT2i have been shown to have a stronger benefit in patients with congestiveheart failure and diabetic kidney disease when compared to their GLP-1RA counterparts. These benefits are not withstanding additional considerations such as cost and the multiple FDA Black Box warnings. This topic is currently an emerging research area and this mini-review paper examines the role of these two novel classes of drugs in patients with T2DM with both confirmed, and at risk for, CVD. | Leonardo Pozo Fatimah Bello Andres Suarez Francisco E Ochoa-Martinez Yamely Mendez Chelsea H Chang Salim Surani | 2019 | World Journal of Diabetes2019，10，5： | 2 |
| 9 | Diabetic ketoacidosis: Treatment in the intensive care unit or general medical/surgical ward?显示文摘Diabetic ketoacidosis(DKA) is defined as an acute metabolic disorder, which is characterized by an increased presence of circulating ketones, and the development of ketoacidosis in the presence of hyperglycemia. This syndrome occurs as a result of insulin deficiency. Patients can be dramatically ill, however, with aggressive treatment, most patients recover rapidly. Despite being a low-risk condition, the development of acidosis, is one of the admission criteria to the intensive care unit(ICU) for these patients, in order to provide close monitoring, and recognize complications that could result from the use of aggressive therapy, such as continuous infusions if insulin. In some institutions, DKA is treated in the emergency department and general medical/surgical wards to avoid ICU overcrowding. | Yamely Mendez Salim Surani Joseph Varon | 2017 | World Journal of Diabetes2017，8，2： | 2 |
| 10 | Clinical characteristics of children with tracheobronchial anomalies 显示文摘 | Sanchez I Navarro H Mendez M | 2003 | Pediatr Pulmonol2003，35，： | 1 |
| 11 | Simultaneous urea hydrolysis, formaldehyde removal and denitrification in a multifed upflow filter under anoxic and anaerobic conditions显示文摘 | Garrido J M Mendez R Lema J M | 2001 | Water Res2001，35，3： | 1 |
| 12 | PPARγ inhibition of cyclooxygenase- 2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes 显示文摘 | Mendez M LaPointe MC | 2003 | Hypertension2003，42，4： | 1 |
| 13 | Congestion management and transmission rights in centralized electric markets显示文摘 | H Rudnick | 2004 | IEEE Transactions on Power Systems2004，19，2： | 1 |
| 14 | Analysis of grass silage from Northwestern spain by near-infrared reflectance spectroscopy显示文摘 | VILLAMARIN B FERNANDEZ E MENDEZ J | 2002 | Journal of AOAC International2002，85，3： | 1 |
| 15 | Interferon regulated path ways that control hepatitis B virus replication in transgenic mice显示文摘 | Guidotti LG Morris A Mendez H | 2002 | J Virol2002，76，6： | 1 |
| 16 | Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease:a pilot study: report of three cases显示文摘 | Mendez I Dagher A Hong M | 2002 | J Neurosurg2002，96，3： | 1 |
| 17 | Heat shock protein 70 binds to human apurinic/apyrimidinic endonuclease and stimulates endonuclease activity at abasic sites 显示文摘 | Kenny M K Mendez F Sandigursky M | 2001 | J Biol Chem2001，276，12： | 1 |
| 18 | Color Quality of Pigments in cochineals (Dactylopius coccus Costa) 显示文摘 | MENDEZ A GONZALEZ J LOBO M | 2004 | Agric Food Chem2004，52，： | 1 |
| 19 | Slip and fatigue crack formation processes in an α/β titanium alloy in relation to crystallographic texture on different scales显示文摘 | BRIDIER F VILLECHAISE P MENDEZ J | 2008 | Acta Materialia2008，56，15： | 1 |
| 20 | A novel role for parkin in trauma-induced central nervous system secondary injury显示文摘 | Mukhida K Kobayashi NR Mendez I | 2005 | Med Hypotheses2005，64，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员